Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

PURPOSE: To evaluate the efficacy of cytokine-induced killer (CIK) cell therapy in the treatment of hepatocellular carcinoma. MATERIALS AND METHODS: Randomized phase II and III trials on CIK cell-based therapy were identified by electronic searches using a combination of "hepatocellular carcino...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ma, Yue, Xu, Ying-Chun, Tang, Lei, Zhang, Zan, Wang, Jian, Wang, Hong-Xia
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Methodology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514101/
https://ncbi.nlm.nih.gov/pubmed/23210562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2162-3619-1-11
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky